Identification of Human Renal Cell Carcinoma Associated Genes by Suppression Subtractive Hybridization

Overview

Journal Br J Cancer

Specialty Oncology

Date 2001 Nov 27

PMID 11720477

Citations 52

Authors

M J Stassar

G Devitt

M BROSIUS

L Rinnab

J Prang

T Schradin

J Simon

S Petersen

A Kopp-Schneider

M Zoller

Affiliations

Soon will be listed here.

Abstract

Renal cell carcinoma (RCC) are frequently chemo- and radiation resistant. Thus, there is a need for identifying biological features of these cells that could serve as alternative therapeutic targets. We performed suppression subtractive hybridization (SSH) on patient-matched normal renal and RCC tissue to identify variably regulated genes. 11 genes were strongly up-regulated or selectively expressed in more than one RCC tissue or cell line. Screening of filters containing cancer-related cDNAs confirmed overexpression of 3 of these genes and 3 additional genes were identified. These 14 differentially expressed genes, only 6 of which have previously been associated with RCC, are related to tumour growth/survival (EGFR, cyclin D1, insulin-like growth factor-binding protein-1 and a MLRQ sub-unit homologue of the NADH:ubiquinone oxidoreductase complex), angiogenesis (vascular endothelial growth factor, endothelial PAS domain protein-1, ceruloplasmin, angiopoietin-related protein 2) and cell adhesion/motility (protocadherin 2, cadherin 6, autotaxin, vimentin, lysyl oxidase and semaphorin G). Since some of these genes were overexpressed in 80-90% of RCC tissues, it is important to evaluate their suitability as therapeutic targets.

Citing Articles

Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments.

Villegas-Vazquez E, Marin-Carrasco F, Reyes-Hernandez O, Baez-Gonzalez A, Bustamante-Montes L, Padilla-Benavides T Front Oncol. 2025; 14:1514120.

PMID: 39876896 PMC: 11772297. DOI: 10.3389/fonc.2024.1514120.

PCDH8 is a novel prognostic biomarker in thyroid cancer and promotes cell proliferation and viability.

Yang R, Yang N, Yin P, Xue Z, Sun F, Fan R Funct Integr Genomics. 2024; 24(2):35.

PMID: 38368303 PMC: 10874333. DOI: 10.1007/s10142-024-01312-3.

Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications.

Drosouni A, Panagopoulou M, Aidinis V, Chatzaki E Cancers (Basel). 2022; 14(21).

PMID: 36358855 PMC: 9658281. DOI: 10.3390/cancers14215437.

gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers.

Wang S, Chen J, Guo X World J Gastrointest Oncol. 2022; 14(8):1388-1405.

PMID: 36160748 PMC: 9412925. DOI: 10.4251/wjgo.v14.i8.1388.

Fibrosis in Mesothelioma: Potential Role of Lysyl Oxidases.

Perryman L, Gray S Cancers (Basel). 2022; 14(4).

PMID: 35205728 PMC: 8870010. DOI: 10.3390/cancers14040981.

References

Xin H, Stephans J, Duan X, Harrowe G, Kim E, Grieshammer U . Identification of a novel aspartic-like protease differentially expressed in human breast cancer cell lines. Biochim Biophys Acta. 2000; 1501(2-3):125-37. DOI: 10.1016/s0925-4439(00)00014-4. View

Gerwins P, Skoldenberg E, Claesson-Welsh L . Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol. 2000; 34(3):185-94. DOI: 10.1016/s1040-8428(00)00062-7. View

Bennett B, Loeloff R, Louis J, Curran E, Citron M, Vassar R . Expression analysis of BACE2 in brain and peripheral tissues. J Biol Chem. 2000; 275(27):20647-51. DOI: 10.1074/jbc.M002688200. View

Moch H, Gasser T, Amin M, Torhorst J, Sauter G, Mihatsch M . Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer. 2000; 89(3):604-14. View

Shimazui T, Oosterwijk-Wakka J, Akaza H, Bringuier P, Ruijter E, Debruyne F . Alterations in expression of cadherin-6 and E-cadherin during kidney development and in renal cell carcinoma. Eur Urol. 2000; 38(3):331-8. DOI: 10.1159/000020302. View

Kaplan C, Morris J, Wu C, Winston F . Spt5 and spt6 are associated with active transcription and have characteristics of general elongation factors in D. melanogaster. Genes Dev. 2000; 14(20):2623-34. PMC: 316994. DOI: 10.1101/gad.831900. View

Yamaguchi Y, Narita T, Inukai N, Wada T, Handa H . SPT genes: key players in the regulation of transcription, chromatin structure and other cellular processes. J Biochem. 2001; 129(2):185-91. DOI: 10.1093/oxfordjournals.jbchem.a002842. View

Jares P, Fernandez P, Campo E, Nadal A, Bosch F, Aiza G . PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 1994; 54(17):4813-7. View

Lager D, Slagel D, Palechek P . The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma. Mod Pathol. 1994; 7(5):544-8. View

10.

Zhang S, Caamano J, Cooper F, Guo X, Klein-Szanto A . Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol. 1994; 102(5):695-8. DOI: 10.1093/ajcp/102.5.695. View

11.

Reis M, Faria V . Renal carcinoma: clinical, diagnostic and prognostic aspects. Arch Esp Urol. 1994; 47(7):739-43. View

12.

Kurzrock R, Ku S, Talpaz M . Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. Cancer. 1995; 75(2):584-90. DOI: 10.1002/1097-0142(19950115)75:2<584::aid-cncr2820750223>3.0.co;2-p. View

13.

Mickisch G . Chemoresistance of renal cell carcinoma: 1986-1994. World J Urol. 1994; 12(4):214-23. DOI: 10.1007/BF00185677. View

14.

Thompson E, Yu M, Bueno J, Jin L, Maiti S, Pulyaeva H . Collagen induced MMP-2 activation in human breast cancer. Breast Cancer Res Treat. 1994; 31(2-3):357-70. DOI: 10.1007/BF00666168. View

15.

Weinberg R . The retinoblastoma protein and cell cycle control. Cell. 1995; 81(3):323-30. DOI: 10.1016/0092-8674(95)90385-2. View

16.

Shimoyama Y, Gotoh M, Terasaki T, Kitajima M, Hirohashi S . Isolation and sequence analysis of human cadherin-6 complementary DNA for the full coding sequence and its expression in human carcinoma cells. Cancer Res. 1995; 55(10):2206-11. View

17.

Weidner N . Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1995; 147(1):9-19. PMC: 1869874. View

18.

Christensen C, Klingelhofer J, Tarabykina S, Hulgaard E, Kramerov D, Lukanidin E . Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res. 1998; 58(6):1238-44. View

19.

Wiesener M, Turley H, Allen W, Willam C, Eckardt K, Talks K . Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood. 1998; 92(7):2260-8. View

20.

Lin B, Brynes R, Gelb A, McCourty A, Amin M, Medeiros L . Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study. Mod Pathol. 1998; 11(11):1075-81. View